DRIO - DarioHealth Corp.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.77
+0.01 (+0.57%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close1.76
Open1.77
Bid1.18 x 500
Ask2.18 x 100
Day's Range1.72 - 1.79
52 Week Range1.40 - 4.70
Volume18,706
Avg. Volume149,057
Market Cap18.12M
Beta-0.84
PE Ratio (TTM)N/A
EPS (TTM)-0.79
Earnings DateNov 8, 2017 - Nov 13, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.25
Trade prices are not sourced from all markets
  • What Can We Expect for DarioHealth Corp (DRIO) Moving Forward?
    Simply Wall St.5 days ago

    What Can We Expect for DarioHealth Corp (DRIO) Moving Forward?

    DarioHealth Corp (NASDAQ:DRIO), a USD$16.18M small-cap, is a healthcare company operating in an industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as anRead More...

  • DarioHealth Reports Third Quarter 2017 Results
    PR Newswire5 days ago

    DarioHealth Reports Third Quarter 2017 Results

    Record Quarterly Revenues of $1.4 Million Continued Reduction in Cash Burn Android and New Initiatives to Accelerate Growth CAESAREA, Israel , Nov. 14, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), ...

  • ACCESSWIRE5 days ago

    DarioHealth Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 14, 2017 / DarioHealth Corp. (NASDAQ: DRIO ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 14, 2017 at 9:00 AM Eastern ...

  • ACCESSWIRE6 days ago

    Investor Network Invites You to the DarioHealth Third Quarter 2017 Earnings Conference Call and Webcast Live on Tuesday, November 14, 2017

    CAESAREA, ISRAEL / ACCESSWIRE / November 13, 2017 / DarioHealth Corp. (NASDAQ: DRIO) will host a conference call and live webcast to discuss the results of third quarter 2017, to be held Tuesday, November ...

  • DarioHealth to Host Third Quarter Conference Call on November 14, 2017
    PR Newswire13 days ago

    DarioHealth to Host Third Quarter Conference Call on November 14, 2017

    Earnings and Business Update Conference Call Scheduled for 9:00am ET CAESAREA, Israel , Nov 6, 2017 , /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO ), a leading global digital health company with mobile ...

  • PR Newswire20 days ago

    DarioHealth Expanding its Mobile Health and Data Offerings to Include a Business-to-Business Solution

    DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it is increasing its B2B2C offering by facilitating organizations to digitize targeted healthcare solutions in patients with diabetes. The strategic move comes on the eve of Diabetes Awareness Month, and DarioHealth has officially launched its new corporate website http://www.dariohealth.com to showcase its first-class capabilities. The new platform, called Dario Engage, helps healthcare providers in all aspects of user engagement, including enrollment, coaching and ongoing communications with the end-users.

  • SmarterAnalystlast month

    DarioHealth Corp (DRIO) Scores CE Mark; Shares Soar 36%

    DarioHealth Corp (NASDAQ:DRIO) investors are overwhelmingly excited after the smartphone-connected glucometer company announced that it is now allowed to place the "CE" Mark on the Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System for distribution in the European Union (EU) and its member states. The news ensures that consumers, beginning in the UK market, will be able to receive the same quality user experience with DarioHealth on the latest Apple devices, including the brand-new iPhone 8. The launch of Apple's smartphones with only a Lightning connector posed a unique challenge to the entire mobile ecosystem.

  • PR Newswirelast month

    DarioHealth Gains CE Mark for iPhone 7 and iPhone 8 Smart Glucose Meter

    CAESAREA, Israel, Oct. 18, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it received the CE Mark for its Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System. The news ensures that consumers, beginning in the UK market, will be able to receive the same quality user experience with DarioHealth on the latest Apple devices, including the brand-new iPhone 8. The launch of Apple's smartphones with only a Lightning connector posed a unique challenge to the entire mobile ecosystem.

  • Should You Sell DarioHealth Corp (DRIO) For This Reason?
    Simply Wall St.2 months ago

    Should You Sell DarioHealth Corp (DRIO) For This Reason?

    As the USD $18.61M market cap DarioHealth Corp (NASDAQ:DRIO) released another year of negative earnings, investors may be on edge waiting for breakeven. Since DRIO is currently burning more cashRead More...

  • DarioHealth Launches into the German Diabetes Market
    PR Newswire2 months ago

    DarioHealth Launches into the German Diabetes Market

    CAESAREA, Israel, Oct. 3, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced it expands its global reach with a successful launch into the German market, making its smart diabetes platform available for the first time in the EU's largest market, both by population and GDP. With this launch, DarioHealth is now commercially available in 9 countries around the world. DarioHealth will operate its direct-to-consumer channel, leveraging its in-depth knowledge from other markets to provide new opportunities for more than 8 million Germans living with diabetes.

  • PR Newswire2 months ago

    DarioHealth's MyDario to Appear on The Dr. Oz Show

    CAESAREA, Israel and NEW YORK, Sept. 27, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced that its MyDario product is expected to appear on The Dr. Oz Show on today. The segment features Tracy Herbert who is passionate about helping people live a healthier life. Tracy has lived with Type 1 diabetes for almost 40 years, which has shaped her thirst for knowledge in health, fitness, and wellness.

  • DarioHealth's CEO and MyDario to Appear on The Dr. Oz Show
    PR Newswire2 months ago

    DarioHealth's CEO and MyDario to Appear on The Dr. Oz Show

    CAESAREA, Israel and NEW YORK, Sept. 26, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced that its CEO, Erez Raphael, and the MyDario product is expected to appear on The Dr. Oz Show on Wednesday, September 27, 2017. The segment features Tracy Herbert who is passionate about helping people live a healthier life.

  • DarioHealth Joins Philips-backed Innovation Hub HighTechXL to Empower More Diabetes Patients to Analyze and Personalize Their Treatment
    PR Newswire2 months ago

    DarioHealth Joins Philips-backed Innovation Hub HighTechXL to Empower More Diabetes Patients to Analyze and Personalize Their Treatment

    CAESAREA, Israel and EINDHOVEN, Netherlands, Sept. 20, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a smart diabetes solution, and HighTechXL, a corporate-backed accelerator based in Eindhoven, The Netherlands, announce their strategic collaboration to bring personalized healthcare management to diabetes and pre-diabetes patients around the world. Backed by an alliance of corporations and regional organizations, including Philips, the HighTechXL Acceleration program selected DarioHealth because of its strong management team, innovative business model, and smart solutions for diabetes management.

  • DarioHealth Corp. :DRIO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
    Capital Cube2 months ago

    DarioHealth Corp. :DRIO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017

    Categories: Yahoo FinanceGet free summary analysis DarioHealth Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of DarioHealth Corp. – Ionis Pharmaceuticals, Inc., Exact Sciences Corporation and Mateon Therapeutics, Inc. (IONS-US, EXAS-US and MATN-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)

  • DarioHealth Launches Its Dario App in the Google Play Store Expanding Its U.S. Market Reach
    PR Newswire2 months ago

    DarioHealth Launches Its Dario App in the Google Play Store Expanding Its U.S. Market Reach

    CAESAREA, Israel, Sept. 7, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced the launch of its Dario app for certain leading Android smart mobile devices (SMD) in the U.S. The company's Dario Blood Glucose Monitoring System (BGMS) is now available and ready to ship its to Android users in the U.S. This launch opens a significant U.S. market opportunity for DarioHealth, as its flagship Dario app is now available in Google Play's U.S. app store for specific SMDs to be used with the Dario BGMS.

  • DarioHealth Closes on $5 Million Through Private Placement Offerings
    PR Newswire3 months ago

    DarioHealth Closes on $5 Million Through Private Placement Offerings

    CAESAREA, Israel, Aug. 23, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health Company with mobile health and big data solutions, announced today that it has closed on concurrent private placement offerings with domestic and non-U.S. investors for the sale of shares of the Company's common stock and shares of the Company's newly designated Series B Convertible Preferred Stock in concurrent private placement offerings. As a part of these private placement transactions, which totals $5 million in the aggregate before expenses and placement agent fees, the Company issued 483,333 shares of common stock at a price per share of $1.80 and 2,307,654 shares of Series B Convertible Preferred Stock at a price per share of $1.80.

  • DarioHealth Raises $4.28 Million Through Private Placement Offerings
    PR Newswire3 months ago

    DarioHealth Raises $4.28 Million Through Private Placement Offerings

    CAESAREA, Israel, August 17, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health Company with mobile health and big data solutions, announced today that it has signed securities purchase agreements with domestic and non-U.S. investors for the sale of shares of the Company's common stock and shares of the Company's newly designated Series B Convertible Preferred Stock in concurrent private placement offerings. The Company expects to conduct a closing with respect to the offerings on or before August 22, 2017. As a part of these private placement transactions, which totals $4.28 million in the aggregate before expenses and placement agent fees, the Company will issue 483,333 shares of common stock at a price per share of $1.80 and 1,894,446 shares of Series B Convertible Preferred Stock at a price per share of $1.80.

  • DarioHealth Reports Second Quarter 2017 Results
    PR Newswire3 months ago

    DarioHealth Reports Second Quarter 2017 Results

    Record Quarterly Revenues of $1.2 Million Sequential Quarterly Revenue Growth of 20% Reduction in Cash Burn CAESAREA, Israel , August 14, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading ...

  • ACCESSWIRE3 months ago

    Investor Network Invites You to the DarioHealth Second Quarter 2017 Earnings Conference Call and Webcast Live on Monday, August 14, 2017

    CAESAREA, ISRAEL / ACCESSWIRE / August 11, 2017 / DarioHealth Corp. (NASDAQ: DRIO) will host a conference call and live webcast to discuss the results of second quarter 2017, to be held Monday, August ...

  • DarioHealth to Host Second Quarter Conference Call on August 14, 2017
    PR Newswire3 months ago

    DarioHealth to Host Second Quarter Conference Call on August 14, 2017

    Earnings and Business Update Conference Call Scheduled for 9:00am ET CAESAREA, Israel , Aug. 11, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile ...

  • DarioHealth Partners with Byram Healthcare to Further Expand Insurance Health Coverage for U.S. Consumers
    PR Newswire4 months ago

    DarioHealth Partners with Byram Healthcare to Further Expand Insurance Health Coverage for U.S. Consumers

    CAESAREA, Israel and NEW YORK, July 25, 2017 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it is expanding its insurance coverage provider network by entering into a strategic agreement with New York-based Byram Healthcare (Byram). As reported last month, DarioHealth expanded its 3rd party insurance coverage option for U.S. consumers who want their DarioHealth products reimbursed by insurance. The addition of Byram to the DarioHealth provider network will further accelerate market penetration in the insurance reimbursable market for DarioHealth's U.S. consumers.

  • DarioHealth Looks to Accelerate Market Penetration with Expanded Health Insurance Coverage to Target up to 10 Million Consumers
    PR Newswire5 months ago

    DarioHealth Looks to Accelerate Market Penetration with Expanded Health Insurance Coverage to Target up to 10 Million Consumers

    CAESAREA, Israel, June 21, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it is expanding its insurance coverage provider network across the U.S. with additional service providers that will be able to target up to 10 million consumers with diabetes. Earlier this year, DarioHealth began offering a 3rd party insurance coverage option for U.S. consumers who wanted to have their DarioHealth products reimbursed by insurance.